These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18757283)

  • 1. Warfarin: an inconvenient truth.
    Gattellari M; Worthington J; Zwar N
    Stroke; 2009 Jan; 40(1):5-7. PubMed ID: 18757283
    [No Abstract]   [Full Text] [Related]  

  • 2. The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.
    Lip GY
    Stroke; 2008 May; 39(5):1406-8. PubMed ID: 18323477
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
    Ford GA; Choy AM; Deedwania P; Karalis DG; Lindholm CJ; Pluta W; Frison L; Olsson SB;
    Stroke; 2007 Nov; 38(11):2965-71. PubMed ID: 17885258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Circulation; 2012 May; 125(19):2298-307. PubMed ID: 22514252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis.
    Berry C; Norrie J; McMurray JJ
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):149-51. PubMed ID: 16025234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Berman JP; Halperin JL
    Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials.
    Liew A; O'Donnell M; Douketis J
    J Thromb Haemost; 2014 Sep; 12(9):1419-24. PubMed ID: 24986568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.
    Senoo K; Lip GY
    Stroke; 2015 Nov; 46(11):3202-7. PubMed ID: 26463692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?
    Eckman MH; Wong LK; Soo YO; Lam W; Yang SR; Greenberg SM; Rosand J
    Stroke; 2008 Dec; 39(12):3308-15. PubMed ID: 18845797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

  • 13. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation for atrial fibrillation: should warfarin be temporarily stopped or continued after acute cardioembolic stroke?
    Mudd PD; James MA
    Age Ageing; 2010 Nov; 39(6):670-3. PubMed ID: 20858671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage occlusion does not eliminate the need for warfarin.
    Whitlock RP; Healey JS; Connolly SJ
    Circulation; 2009 Nov; 120(19):1927-32; discussion 1932. PubMed ID: 19901203
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
    Fang MC; Go AS; Chang Y; Hylek EM; Henault LE; Jensvold NG; Singer DE
    Am J Med; 2007 Aug; 120(8):700-5. PubMed ID: 17679129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.
    Jolobe OM
    J Am Geriatr Soc; 2008 Oct; 56(10):1967-8. PubMed ID: 19054207
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal timing of resumption of warfarin after intracranial hemorrhage.
    Majeed A; Kim YK; Roberts RS; Holmström M; Schulman S
    Stroke; 2010 Dec; 41(12):2860-6. PubMed ID: 21030703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.